Resultats de la cerca - Tommy Förnander

Refinar resultats
  1. 1
    Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer

    Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer per Lars Erik Rutqvist, Ingmar Lax, Tommy� Fornander, Hemming Johansson

    Publicat 1992
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Factors influencing return to work: a narrative study of women treated for breast cancer

    Factors influencing return to work: a narrative study of women treated for breast cancer per Aina Johnsson, Tommy Förnander, L. E. Rutqvist, Mariann Olsson

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Estrogen Receptor-α Phosphorylation at Serine 305, Nuclear p21-Activated Kinase 1 Expression, and Response to Tamoxifen in Postmenopausal Breast Cancer

    Estrogen Receptor-α Phosphorylation at Serine 305, Nuclear p21-Activated Kinase 1 Expression, and Response to Tamoxifen in Postmenopausal Breast Cancer per Josefine Bostner, Lambert Skoog, Tommy� Fornander, Bo Nordenskjöld, Olle Stål

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Bone Mineral Density Among Premenopausal Women With Early Breast Cancer in a Randomized Trial of Adjuvant Endocrine Therapy

    Bone Mineral Density Among Premenopausal Women With Early Breast Cancer in a Randomized Trial of Adjuvant Endocrine Therapy per Ásgerður Sverrisdóttir, Tommy Förnander, Hans Jacobsson, E. von Schoultz, L. E. RUTQVIST

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer

    Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer per Erik Hilborn, Jelena Gacic, Tommy Förnander, Bo Nordenskjöld, Olle Stål, Agneta Jansson

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Predictors of return to work ten months after primary breast cancer surgery

    Predictors of return to work ten months after primary breast cancer surgery per Aina Johnsson, Tommy Förnander, Lars‐Erik Rutqvist, Marjan Vaez, Kristina Alexanderson, Mariann Olsson

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Factors associated with return to work after breast cancer treatment

    Factors associated with return to work after breast cancer treatment per Aina Johnsson, Tommy� Fornander, Mariann Olsson, Marianne Nystedt, Hemming Johansson, Lars Erik Rutqvist

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit

    Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit per Josefine Bostner, Elin Karlsson, Muneeswaran Jayachandra Pandiyan, Hanna Westman, Lambert Skoog, Tommy� Fornander, Bo Nordenskjöld, Olle Stål

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen

    Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen per Mahmoud R. Khoshnoud, Britta Löfdahl, Helena Fohlin, Tommy� Fornander, Olle Stål, Lambert Skoog, Jonas Bergh, Bo Nordenskjöld

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas

    PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas per Michaela Aubele, Gert Auer, Axel Walch, Alison F. Munro, Michael J. Atkinson, Herbert Braselmann, Tommy� Fornander, John M.S. Bartlett

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Tumor Stage Affects Risk and Prognosis of Contralateral Breast Cancer: Results From a Large Swedish-Population–Based Study

    Tumor Stage Affects Risk and Prognosis of Contralateral Breast Cancer: Results From a Large Swedish-Population–Based Study per Voralak Vichapat, Hans Garmo, Marit Holmqvist, Göran Liljegren, Fredrik Wärnberg, Mats Lambe, Tommy� Fornander, Jan Adolfsson, Margreet Lüchtenborg, Lars Holmberg

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials

    The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patien... per Elin Karlsson, Gizeh Pérez‐Tenorio, Risul Amin, Josefine Bostner, Lambert Skoog, Tommy� Fornander, Dennis C. Sgroi, Bo Nordenskjöld, Anna‐Lotta Hallbeck, Olle Stål

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer

    Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer per A. Hackshaw, Michael Baum, Tommy� Fornander, Bo Nordenskjöld, Antonio Nicolucci, Kathryn Monson, Sharon Forsyth, Krystyna Reczko, Unn‐Britt Johansson, Helena Fohlin, Umberto Valentini, R Sainsbury

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer

    ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer per Subrata Manna, Josefine Bostner, Yang Sun, Lance D. Miller, Anya Alayev, Naomi Schwartz, Elin Lager, Tommy Förnander, Bo Nordenskjöld, Jane Yu, Olle Stål, Marina K. Holz

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Breast Cancer Index Identifies Early-Stage Estrogen Receptor–Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence

    Breast Cancer Index Identifies Early-Stage Estrogen Receptor–Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence per Yi Zhang, Catherine A. Schnabel, Brock E. Schroeder, Piiha-Lotta Jerevall, Rachel C. Jankowitz, Tommy� Fornander, Olle Stål, Adam Brufsky, Dennis C. Sgroi, Mark G. Erlander

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

    Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial per P-L Jerevall, X-J Ma, Huan Li, Ranelle Salunga, Nicole C. Kesty, Mark G. Erlander, Dennis C. Sgroi, Birgitta Holmlund, Lambert Skoog, Tommy� Fornander, Bo Nordenskjöld, Olle Stål

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades

    Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades per Laura J. Esserman, Christina Yau, Carlie K. Thompson, Laura van ‘t Veer, Alexander D. Borowsky, Katherine A. Hoadley, Nicholas P. Tobin, Bo Nordenskjöld, Tommy� Fornander, Olle Stål, Christopher C. Benz, Linda S. Lindström

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer

    Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer per Nancy Yu, Adina Iftimi, Christina Yau, Nicholas P. Tobin, Laura van ‘t Veer, Katherine A. Hoadley, Christopher C. Benz, Bo Nordenskjöld, Tommy Förnander, Olle Stål, Kamila Czene, Laura J. Esserman, Linda S. Lindström

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study

    Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study per Sarah Walters, Camille Maringe, J. Butler, Bernard Rachet, Peter Barrett‐Lee, Jonas Bergh, John Boyages, Peer Christiansen, M. Lee, Fredrik Wärnberg, Claudia Allemani, Gerda Engholm, Tommy� Fornander, ML Gjerstorff, Tom Børge Johannesen, Gill Lawrence, C E McGahan, Richard Middleton, John Steward, Elizabeth Tracey, Donna Turner, Martin Richards, Michel P. Coleman

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer

    Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer per Linda S. Lindström, Christina Yau, Kamila Czene, Carlie K. Thompson, Katherine A. Hoadley, Laura J. vanʼt Veer, Ronald Balassanian, John W. Bishop, Philip M. Carpenter, Yunn‐Yi Chen, Brian Datnow, Farnaz Hasteh, Gregor Krings, Fritz Lin, Yanhong Zhang, Bo Nordenskjöld, Olle Stål, Christopher C. Benz, Tommy� Fornander, Alexander D. Borowsky, Laura J. Esserman

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: